Chimerix Inc. (CMRX)

2.20
NASDAQ : Health Technology
Prev Close 2.35
Day Low/High 2.18 / 2.50
52 Wk Low/High 1.74 / 4.40
Avg Volume 370.90K
Exchange NASDAQ
Shares Outstanding 61.27M
Market Cap 143.98M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Chimerix Reaches Analyst Target Price

Chimerix Reaches Analyst Target Price

In recent trading, shares of Chimerix Inc. have crossed above the average analyst 12-month target price of $3.50, changing hands for $3.51/share.

Chimerix Is Now Oversold (CMRX)

Chimerix Is Now Oversold (CMRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Bullish Two Hundred Day Moving Average Cross - CMRX

Bullish Two Hundred Day Moving Average Cross - CMRX

In trading on Thursday, shares of Chimerix Inc. crossed above their 200 day moving average of $4.88, changing hands as high as $4.96 per share.

Chimerix Is Now Oversold (CMRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

The AdVance Study: A Landmark Natural History Study Of Adenovirus In Allogeneic Hematopoietic Cell Transplant Shows Strong Correlation Between Disease Burden And Mortality Risk

The AdVance Study: A Landmark Natural History Study Of Adenovirus In Allogeneic Hematopoietic Cell Transplant Shows Strong Correlation Between Disease Burden And Mortality Risk

European, multi-center study reinforces need for effective therapies for adenovirus in immunocompromised patients

Short Interest Decreases By 29.8% For CMRX

Short Interest Decreases By 29.8% For CMRX

The most recent short interest data has been released for the 12/15/2017 settlement date, which shows a 420,271 share decrease in total short interest for Chimerix Inc. , to 991,847, a decrease of 29.76% since 11/30/2017.

Chimerix Becomes Oversold (CMRX)

Chimerix Becomes Oversold (CMRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Chimerix Announces Third Quarter 2017 Financial Results

Chimerix Announces Third Quarter 2017 Financial Results

Conference Call at 8:30 a.m. ET Today

Chimerix Stock Sees Short Interest Decline 40%

Chimerix Stock Sees Short Interest Decline 40%

The most recent short interest data has been released for the 09/29/2017 settlement date, which shows a 869,710 share decrease in total short interest for Chimerix Inc. , to 1,310,240, a decrease of 39.90% since 09/15/2017.

Chimerix Announces Second Quarter 2017 Financial Results

Chimerix Announces Second Quarter 2017 Financial Results

- Conference Call at 8:30 a.m. ET Today -

Oversold Conditions For Chimerix (CMRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Chimerix Announces First Quarter 2017 Financial Results

- Conference Call at 8:30 a.m. ET Today -

Chimerix is Now Oversold (CMRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting CMRX Put And Call Options For November 17th

Investors in Chimerix Inc. saw new options begin trading this week, for the November 17th expiration.

TheStreet Quant Rating: D (Sell)